Nov 28, 2023 activistcompany

Soleus Pressures Theratechnologies (THTX) to Consider Future Pak’s $3.51 Buyout Offer

Key Summary: Soleus Capital (10.5%) has pushed Theratechnologies since November 2023 to enhance shareholder value, including board changes and exploring strategic options. On April 11, 2025, it urged the Board to consider Future Pak’s $3.51 all-cash offer, criticizing management for ignoring buyers and acting in self-interest.

Market Cap: $89 million | Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

On November 28, 2023, Soleus Capital (10.5%) communicated with the Board and management about enhancing stockholder value, including the potential appointment of a designated candidate to the Board and engaging an investment bank for strategic transactions. Source

On April 11, 2025, Soleus Capital urged Theratechnologies to engage with Future Pak’s acquisition offer of at least $3.51 per share—a 163% premium—criticizing management for not constructively engaging with potential buyers. Soleus warned that repeated rejections suggest management is acting in self-interest and urged the Board to fulfill its fiduciary duty by seriously considering and presenting the offer to shareholders.

More like this

Daniel S. Farb nominated Board Candidates to Artelo Biosciences, Inc (ARTL)

Khrom Capital urges Acadia Healthcare Company, Inc (ACHC) for Strategic Review and Potential Sale

Alden Global increased its stake after reaching Cooperation Agreement with Freds Inc. (FRED)

Alden Global reduced its stake below 5% in Pier 1 Imports (PIR)

JCP Investment Management Sees Earnings Growth Potential, Plans Engagement with Board of Denny's Corporation (DENN)

Lakeview Investment Group reaches agreement with TESSCO